The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer

Naoko Inoshima, Yoichi Nakanishi, Takahiro Minami, Miiru Izumi, Koichi Takayama, Ichiro Yoshino, Nobuyuki Hara

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

Vascular endothelial growth factor (VEGF) is well known to be produced by many human tumors, and it also plays an important role in tumor neovasculature formation. In addition to angiogenesis promotion, recent basic research has shown that VEGF has another function that allows it to inhibit dendritic cell (DC) maturation. However, very little is known about VEGF-dependent DC inhibition in a clinical setting. In this study, we analyzed the immunohistochemical expression of VEGF, microvessel density (MVD), and intratumoral DC infiltration in 132 surgically resected lung cancer specimens. We also evaluated the influence of these factors on their survival by a multivariate statistical analysis. VEGF expression was positively related to MVD (P = 0.0003) and negatively related to the degree of DC infiltration (P = 0.0232). A multivariate analysis also showed the VEGF expression, MVD, and DC infiltration to be independent prognostic factors. Moreover, we also accurately analyzed patient prognoses using the double stratification method for determining VEGF expression and DC infiltration. The patient group with a high VEGF expression/low DC infiltration showed a worse prognosis (P < 0.0001), whereas the group with a low VEGF expression/high DC infiltration had a better prognosis (P = 0.0001).

Original languageEnglish
Pages (from-to)3480-3486
Number of pages7
JournalClinical Cancer Research
Volume8
Issue number11
Publication statusPublished - Nov 1 2002

Fingerprint

Non-Small Cell Lung Carcinoma
Dendritic Cells
Vascular Endothelial Growth Factor A
Microvessels
Multivariate Analysis
Lung Neoplasms
Neoplasms
Survival
Research

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Inoshima, N., Nakanishi, Y., Minami, T., Izumi, M., Takayama, K., Yoshino, I., & Hara, N. (2002). The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer. Clinical Cancer Research, 8(11), 3480-3486.

The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer. / Inoshima, Naoko; Nakanishi, Yoichi; Minami, Takahiro; Izumi, Miiru; Takayama, Koichi; Yoshino, Ichiro; Hara, Nobuyuki.

In: Clinical Cancer Research, Vol. 8, No. 11, 01.11.2002, p. 3480-3486.

Research output: Contribution to journalArticle

Inoshima, N, Nakanishi, Y, Minami, T, Izumi, M, Takayama, K, Yoshino, I & Hara, N 2002, 'The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer', Clinical Cancer Research, vol. 8, no. 11, pp. 3480-3486.
Inoshima, Naoko ; Nakanishi, Yoichi ; Minami, Takahiro ; Izumi, Miiru ; Takayama, Koichi ; Yoshino, Ichiro ; Hara, Nobuyuki. / The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer. In: Clinical Cancer Research. 2002 ; Vol. 8, No. 11. pp. 3480-3486.
@article{f93654209593437fb0e056e4d07976b2,
title = "The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer",
abstract = "Vascular endothelial growth factor (VEGF) is well known to be produced by many human tumors, and it also plays an important role in tumor neovasculature formation. In addition to angiogenesis promotion, recent basic research has shown that VEGF has another function that allows it to inhibit dendritic cell (DC) maturation. However, very little is known about VEGF-dependent DC inhibition in a clinical setting. In this study, we analyzed the immunohistochemical expression of VEGF, microvessel density (MVD), and intratumoral DC infiltration in 132 surgically resected lung cancer specimens. We also evaluated the influence of these factors on their survival by a multivariate statistical analysis. VEGF expression was positively related to MVD (P = 0.0003) and negatively related to the degree of DC infiltration (P = 0.0232). A multivariate analysis also showed the VEGF expression, MVD, and DC infiltration to be independent prognostic factors. Moreover, we also accurately analyzed patient prognoses using the double stratification method for determining VEGF expression and DC infiltration. The patient group with a high VEGF expression/low DC infiltration showed a worse prognosis (P < 0.0001), whereas the group with a low VEGF expression/high DC infiltration had a better prognosis (P = 0.0001).",
author = "Naoko Inoshima and Yoichi Nakanishi and Takahiro Minami and Miiru Izumi and Koichi Takayama and Ichiro Yoshino and Nobuyuki Hara",
year = "2002",
month = "11",
day = "1",
language = "English",
volume = "8",
pages = "3480--3486",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer

AU - Inoshima, Naoko

AU - Nakanishi, Yoichi

AU - Minami, Takahiro

AU - Izumi, Miiru

AU - Takayama, Koichi

AU - Yoshino, Ichiro

AU - Hara, Nobuyuki

PY - 2002/11/1

Y1 - 2002/11/1

N2 - Vascular endothelial growth factor (VEGF) is well known to be produced by many human tumors, and it also plays an important role in tumor neovasculature formation. In addition to angiogenesis promotion, recent basic research has shown that VEGF has another function that allows it to inhibit dendritic cell (DC) maturation. However, very little is known about VEGF-dependent DC inhibition in a clinical setting. In this study, we analyzed the immunohistochemical expression of VEGF, microvessel density (MVD), and intratumoral DC infiltration in 132 surgically resected lung cancer specimens. We also evaluated the influence of these factors on their survival by a multivariate statistical analysis. VEGF expression was positively related to MVD (P = 0.0003) and negatively related to the degree of DC infiltration (P = 0.0232). A multivariate analysis also showed the VEGF expression, MVD, and DC infiltration to be independent prognostic factors. Moreover, we also accurately analyzed patient prognoses using the double stratification method for determining VEGF expression and DC infiltration. The patient group with a high VEGF expression/low DC infiltration showed a worse prognosis (P < 0.0001), whereas the group with a low VEGF expression/high DC infiltration had a better prognosis (P = 0.0001).

AB - Vascular endothelial growth factor (VEGF) is well known to be produced by many human tumors, and it also plays an important role in tumor neovasculature formation. In addition to angiogenesis promotion, recent basic research has shown that VEGF has another function that allows it to inhibit dendritic cell (DC) maturation. However, very little is known about VEGF-dependent DC inhibition in a clinical setting. In this study, we analyzed the immunohistochemical expression of VEGF, microvessel density (MVD), and intratumoral DC infiltration in 132 surgically resected lung cancer specimens. We also evaluated the influence of these factors on their survival by a multivariate statistical analysis. VEGF expression was positively related to MVD (P = 0.0003) and negatively related to the degree of DC infiltration (P = 0.0232). A multivariate analysis also showed the VEGF expression, MVD, and DC infiltration to be independent prognostic factors. Moreover, we also accurately analyzed patient prognoses using the double stratification method for determining VEGF expression and DC infiltration. The patient group with a high VEGF expression/low DC infiltration showed a worse prognosis (P < 0.0001), whereas the group with a low VEGF expression/high DC infiltration had a better prognosis (P = 0.0001).

UR - http://www.scopus.com/inward/record.url?scp=0036849944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036849944&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 3480

EP - 3486

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 11

ER -